Form 483

Sharp Sterile Manufacturing, LLC Form 483, 2020-10-27

FDA issued a Form 483 to Sharp Sterile Manufacturing, LLC on 2020-10-27 with 6 public-safe observations.

483· Form 483 issuedHuman Drugs6 observations

Sharp Sterile Manufacturing, LLC · Lee, United States · Issued October 27, 2020

Overview

  • 6 public-safe observations are available for this inspection.
  • 6 structured CFR citations are represented.
  • 1 investigator is tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

27 Oct 2020
21 CFR 211.100(b)

Procedure Deviations Recorded and Justified

Cited by Sony Mathews

27 Oct 2020
21 CFR 211.103

Actual vs. theoretical yields not determined

Cited by Sony Mathews

27 Oct 2020
21 CFR 211.113(b)

Procedures for sterile drug products

Cited by Sony Mathews

27 Oct 2020
21 CFR 211.22(d)

Procedures not in writing, fully followed

Cited by Sony Mathews

27 Oct 2020
21 CFR 211.67(b)

Written procedures not established/followed

Cited by Sony Mathews

Inspected site

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 211.100(b)Cited across public-safe Form 483 observations1x
21 CFR 211.103Cited across public-safe Form 483 observations1x
21 CFR 211.113(b)Cited across public-safe Form 483 observations1x
21 CFR 211.22(d)Cited across public-safe Form 483 observations1x
21 CFR 211.67(b)Cited across public-safe Form 483 observations1x
21 CFR 211.68(b)Cited across public-safe Form 483 observations1x

Source document

PDF
PDF available

Form 483 source document

The source document is available to authorized Atlas users.

Full 483 report

Get the verbatim text of all 6 observations

The source PDF, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere